Skip to search formSkip to main contentSkip to account menu

QMF149

National Institutes of Health

Related topics

Related topics

3 relations

Broader (3)

Drug CombinationsIndansQuinolones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
P224 Efficacy and long-term safety of QMF149 (indacaterol acetate/mometasone furoate) versus mometasone furoate and versus salmeterol xinafoate/fluticasone propionate in patients with inadequately…
Rationale Long-Acting Beta2-Agonist/Inhaled Corticosteroids (LABA/ICS) Fixed-Dose Combinations (FDCs) have been found to be safe… 
2018
2018
Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD…
Background and purpose Fixed-dose combinations of a long-acting beta agonist and an inhaled corticosteroid are more effective… 
2016
2016
Pharmacokinetics of indacaterol and mometasone furoate delivered alone or in a free or fixed dose combination in healthy subjects.
2016
2016
Lung Delivery of Indacaterol and Mometasone Furoate Following Inhalation of QMF149 in Healthy Volunteers
This single‐dose, 4‐period crossover study evaluated the pharmacokinetics (PK) of the β2‐agonist indacaterol maleate and the… 
2015
2015
Pharmacokinetics of QMF149 in Japanese versus Caucasian subjects: an open-label, randomized phase I study.
OBJECTIVES This study aimed to evaluate influence of ethnic factors on the pharmacokinetics of orally inhaled QMF149, a novel… 
2014
2014
P251 Efficacy And Safety Of Once-daily Indacaterol/mometasone Compared With Twice-daily Salmeterol/fluticasone In Patients With Moderate To Very Severe Copd
Introduction QMF149 is an investigational inhaled fixed-dose combination of indacaterol acetate and mometasone furoate via the… 
2012
2012
Safety of once-daily QMF149 in patients with persistent asthma
QMF is an investigational once-daily (QD), fixed-dose combination of indacaterol (IND) and mometasone furoate (MF). This study… 
2012
2012
Long-term efficacy of QMF149 in persistent asthma
QMF is an investigational once-daily (QD) fixed-dose combination of indacaterol (IND) and mometasone furoate (MF). The efficacy… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)